Antag Therapeutics
Develops GIP receptor antagonist therapies for obesity and diabetes.
$84M Series A ·
Source: startupintros.com
Funding history ↓Signals
Website registeredJan 3, 2023 (3 years old)
Funding rounds
- Series A · $84MSource: startupintros.com
- Website created
Companies like Antag Therapeutics
CCliviSeed
EEngimmune Therapeutics$16M Seed · May 2022TT-Knife$110M Series B+ · Aug 2021
VVerdiva Bio$410M Series A · Jan 2025
HHawkhill TherapeuticsSeed · Jun 2026
HHelicoreSeries A · Jan 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/antag-therapeutics (get a free API key).